Specialty Pharmacy: High Tech, High Touch

The specialty pharmacy market continues to grow, and with 60% of the drugs in phase 3 clinical trials considered specialty drugs, 47% of the pharmacy industry’s revenues are projected to come from specialty drugs by 2022, according to the “2018-19 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors” (Adam J. Fein, Ph.D., Drug Channels Institute, October 2018). read more